120 related articles for article (PubMed ID: 17598951)
1. Effects of loperamide on mechanical allodynia induced by herpes simplex virus type-1 in mice.
Sasaki A; Nakashima Y; Takasaki I; Andoh T; Shiraki K; Kuraishi Y
J Pharmacol Sci; 2007 Jul; 104(3):218-24. PubMed ID: 17598951
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
Shannon HE; Lutz EA
Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
[TBL] [Abstract][Full Text] [Related]
3. Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats.
He SQ; Yang F; Perez FM; Xu Q; Shechter R; Cheong YK; Carteret AF; Dong X; Sweitzer SM; Raja SN; Guan Y
Pain; 2013 Nov; 154(11):2477-2486. PubMed ID: 23880055
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection.
Takasaki I; Andoh T; Nojima H; Shiraki K; Kuraishi Y
J Pharmacol Exp Ther; 2001 Feb; 296(2):270-5. PubMed ID: 11160607
[TBL] [Abstract][Full Text] [Related]
5. Relative contribution of peripheral versus central opioid receptors to antinociception.
Labuz D; Mousa SA; Schäfer M; Stein C; Machelska H
Brain Res; 2007 Jul; 1160():30-8. PubMed ID: 17599812
[TBL] [Abstract][Full Text] [Related]
6. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury.
Guan Y; Johanek LM; Hartke TV; Shim B; Tao YX; Ringkamp M; Meyer RA; Raja SN
Pain; 2008 Aug; 138(2):318-329. PubMed ID: 18276075
[TBL] [Abstract][Full Text] [Related]
7. Peripheral opioids act as analgesics in bone cancer pain in mice.
Menéndez L; Lastra A; Hidalgo A; Meana A; García E; Baamonde A
Neuroreport; 2003 May; 14(6):867-9. PubMed ID: 12858049
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
Shinohara A; Andoh T; Saiki I; Kuraishi Y
Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
[TBL] [Abstract][Full Text] [Related]
10. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
11. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
12. Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors.
Shinoda K; Hruby VJ; Porreca F
Neurosci Lett; 2007 Jan; 411(2):143-6. PubMed ID: 17110034
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
14. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
[TBL] [Abstract][Full Text] [Related]
15. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
16. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
[TBL] [Abstract][Full Text] [Related]
17. Antiallodynic effects of loperamide and fentanyl against topical capsaicin-induced allodynia in unanesthetized primates.
Butelman ER; Harris TJ; Kreek MJ
J Pharmacol Exp Ther; 2004 Oct; 311(1):155-63. PubMed ID: 15152028
[TBL] [Abstract][Full Text] [Related]
18. Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
Binder W; Machelska H; Mousa S; Schmitt T; Rivière PJ; Junien JL; Stein C; Schäfer M
Anesthesiology; 2001 Jun; 94(6):1034-44. PubMed ID: 11465595
[TBL] [Abstract][Full Text] [Related]
19. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]